UK Regulators Warn Against Misuse of Weight-Loss Injections

Health officials stress that obesity drugs should only be used under medical supervision and for their intended purposes.

UK's Medicines and Healthcare products Regulatory Agency (MHRA) has urged doctors to monitor for misuse of obesity injections like Wegovy and Mounjaro.
Reports indicate that non-obese individuals are using these drugs for cosmetic weight loss, leading to serious health issues such as malnutrition.
Health Secretary Wes Streeting emphasized that these drugs are not quick fixes for aesthetic purposes and should be taken responsibly.
Common side effects of these weight-loss jabs include gastrointestinal issues, with some cases leading to severe dehydration.
Authorities warn against purchasing these drugs online due to the risk of counterfeit products, including some containing insulin.